(Q24197779)

English

Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

0 references

0 references

Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation (English)

0 references

0 references

platelet transfusion

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Simon Stanworth

2

0 references

3

0 references

4

0 references

Lise J Estcourt

object named as

Lise Estcourt

1

0 references

6

object named as

Alan Tinmouth

0 references

author name string

Michael F Murphy

5

0 references

Nancy Heddle

7

0 references

publication date

16 May 2012

0 references

Cochrane Database of Systematic Reviews

0 references

A prospective randomized trial of a prophylactic platelet transfusion trigger of 10 x 10(9) per L versus 30 x 10(9) per L in allogeneic hematopoietic progenitor cell transplant recipients.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

The Prophylactic Treatment of Thrombocytopenic Leukemic Patients with Platelets: a Double Blind Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Indications for platelet transfusion in children with acute leukemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Methods for the analysis of bleeding outcomes in randomized trials of PLT transfusion triggers.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

A descriptive analysis of international transfusion practice and bleeding outcomes in patients with acute leukemia.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Prophylactic Platelet Transfusions in Children with Acute Leukemia: A Dose Response Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

The efficiency of transfusing high doses of platelets in hematologic patients with thrombocytopenia: results of a prospective, randomized, open, blinded end point (PROBE) study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Dose of prophylactic platelet transfusions and prevention of hemorrhage

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Low-dose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor cell transplant and patients with acute leukemia: a randomized controlled trial with a sequential Bayesian design.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

A prospective randomized study of three types of platelet concentrates in patients with haematological malignancy: corrected platelet count increments and frequency of nonhaemolytic febrile transfusion reactions

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

A randomized, controlled trial of platelet transfusions in thrombocytopenic premature infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

The frequency of bleeding complications in patients with haematological malignancy following the introduction of a stringent prophylactic platelet transfusion policy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Evaluation of platelet transfusion triggers in a tertiary-care hospital

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Reticulated platelets: a reliable measure to reduce prophylactic platelet transfusions after intensive chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Lower or higher doses for prophylactic platelet transfusions: results of a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Platelet transfusions in children: results of a randomized, prospective, crossover trial of plasma removal and a prospective audit of WBC reduction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Ex vivo expansion of megakaryocyte precursor cells in autologous stem cell transplantation for relapsed malignant lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

A randomized study of buffy coat platelets in platelet additive solution stored 1-5 versus 6-7 days prior to prophylactic transfusion of allogeneic haematopoietic progenitor cell transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006).

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Cost of chemotherapy-induced thrombocytopenia among patients with lymphoma or solid tumors

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Conservative Management of Chemotherapeutic-Induced Thrombocytopenia in Women with Gynecologic Cancers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Fresh frozen plasma and platelet transfusion for nonbleeding patients in the intensive care unit: benefit or harm?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Testing platelet mass versus platelet count to guide platelet transfusions in the neonatal intensive care unit

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Platelet utilization and the transfusion trigger: a prospective analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

The role of the plasma from platelet concentrates in transfusion reactions

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to platelets

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

A randomized controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced platelets

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Methodologic issues in the use of bleeding as an outcome in transfusion medicine studies.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Proactive administration of platelets and plasma for patients with a ruptured abdominal aortic aneurysm: evaluating a change in transfusion practice.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Transfusion efficacy of ABO major-mismatched platelets (PLTs) in children is inferior to that of ABO-identical PLTs

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Clinical consequences of alterations in platelet transfusion dose: a prospective, randomized, double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Lowering the prophylactic platelet transfusion threshold: a prospective analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

ABO compatibility can influence the results of platelet transfusion. Results of a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

A multi-centre study of therapeutic efficacy and safety of platelet components treated with amotosalen and ultraviolet A pathogen inactivation stored for 6 or 7 d prior to transfusion.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: an analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

A prospective randomized trial of HLA-matched versus mismatched single-donor platelet transfusions in cancer patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 x 10(9) and 20 x 10(9) per L.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Prevention of alloimmunization in patients with acute leukemia by use of white cell-reduced blood components--a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Adverse reactions to platelet transfusions are reduced by use of platelet concentrates derived from buffy coat

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Evaluation of the effects of different transfusion trigger levels during the treatment of childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

National comparative audit of the use of platelet transfusions in the UK.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Prophylactic platelet administration during massive transfusion. A prospective, randomized, double-blind clinical study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Perioperative platelet transfusion: recommendations of the Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSaPS) 2003.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

ABO-identical versus nonidentical platelet transfusion: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Management of bleeding and of invasive procedures in patients with platelet disorders and/or thrombocytopenia: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET).

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Factors influencing moderate to severe reactions to PLT transfusions: experience of the TRAP multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Design of clinical trials to evaluate the efficacy of platelet transfusion: the euroSPRITE trial for components treated with Helinx technology.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Platelet transfusions in clinical practice at a multidisciplinary hospital in North India.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Acetaminophen and diphenhydramine as premedication for platelet transfusions: a prospective randomized double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Low levels of prothrombin time (INR) and platelets do not increase the risk of significant bleeding when placing central venous catheters.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions? Background, rationale, and design of a clinical trial (trial of platelet prophylaxis) to assess the effectiveness of prophylactic plat

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Guidelines for the use of platelet transfusions

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Hemostatic Function, Survival, and Membrane Glycoprotein Changes in Young versus Old Rabbit Platelets

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

THE RELATION OF BLOOD PLATELETS TO HEMORRHAGIC DISEASE

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Platelet transfusions for patients with haematological malignancies: who needs them?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

The quantitative relation between platelet count and hemorrhage in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Comparing the efficacy and safety of apheresis and whole blood-derived platelet transfusions: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Mathematical modeling of platelet survival with implications for optimal transfusion practice in the chronically platelet transfusion-dependent patient

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Measurement of bleeding severity: a critical review

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Platelets, petechiae, and preservation of the vascular wall

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Accuracy of platelet counting haematology analysers in severe thrombocytopenia and potential impact on platelet transfusion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Controversies in platelet transfusion therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Platelet transfusion prophylaxis for patients with haematological malignancies: where to now?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Prophylactic platelet transfusions: which dose is the best dose? A review of the literature

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

21 January 2018

The bleeding risk index

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet prophylaxis in acute non-lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective, randomized study of the use of platelet concentrates irradiated with ultraviolet-B light in patients with hematologic malignancy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: a prospective, randomized study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of prestorage WBC-reduced whole-blood-derived platelets and bedside-filtered whole-blood-derived platelets in autologous progenitor cell transplant

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Economic consequences of alterations in platelet transfusion dose: analysis of a prospective, randomized, double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Blood collection and transfusion in the United States in 1997

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10,000/L versus 20,000/microL trigger

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of leucocyte-poor blood components and HLA-matched-platelet donors to prevent HLA alloimmunization

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Transfusion of ABO-mismatched platelets leads to early platelet refractoriness

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjudicating bleeding events in a platelet dose study: impact on outcome results and challenges

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial comparing the use of fresh and stored platelets in the treatment of bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of ABO matching in platelet transfusion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Transfusion of platelet concentrates--clinical evaluation of two preparations

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence-based platelet transfusion guidelines

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

New strategies for the optimal use of platelet transfusions

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comprehensive criteria for assessing therapy-induced toxicity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004269.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/14651858.CD004269.PUB3

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24197779&oldid=2105021403"